MIR3118-3

Across TCGA pan-cancer cohorts, MIR3118-3 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated MIR3118-3 data layer.

The strongest signal is observed in acute myeloid leukemia (LAML), where higher MIR3118-3 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR3118-3 expression acts as an unfavorable survival marker.

LAML and THYM are the cancer types where MIR3118-3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LAML	DFS	Tertile	All	0.056	0.572	.001	36	view →
THYM	DFS	Tertile	All	0.174	0.759	.028	27	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

MIR3118-3–LAML (DFS)

Open the LAML breakdown →